Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in …

P Godoy, NJ Hewitt, U Albrecht, ME Andersen… - Archives of …, 2013 - Springer
This review encompasses the most important advances in liver functions and hepatotoxicity
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …

Graphene-based 3D scaffolds in tissue engineering: fabrication, applications, and future scope in liver tissue engineering

R Geetha Bai, K Muthoosamy, S Manickam… - International journal …, 2019 - Taylor & Francis
Tissue engineering embraces the potential of recreating and replacing defective body parts
by advancements in the medical field. Being a biocompatible nanomaterial with outstanding …

In vitro models for liver toxicity testing

VY Soldatow, EL LeCluyse, LG Griffith… - Toxicology …, 2013 - academic.oup.com
Over the years, various liver-derived in vitro model systems have been developed to enable
investigation of the potential adverse effects of chemicals and drugs. Liver tissue slices …

A critical perspective on 3D liver models for drug metabolism and toxicology studies

AS Serras, JS Rodrigues, M Cipriano… - Frontiers in cell and …, 2021 - frontiersin.org
The poor predictability of human liver toxicity is still causing high attrition rates of drug
candidates in the pharmaceutical industry at the non-clinical, clinical, and post-marketing …

Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes

M Kim, JY Lee, CN Jones, A Revzin, G Tae - Biomaterials, 2010 - Elsevier
Primary hepatocytes are commonly used as liver surrogates in toxicology and tissue
engineering fields, therefore, maintenance of functional hepatocytes in vitro is an important …

Present status and perspectives of cell-based therapies for liver diseases

A Nussler, S Konig, M Ott, E Sokal, B Christ… - Journal of …, 2006 - Elsevier
In recent years the interest in liver cell therapy has been increasing continuously, since the
demand for whole liver transplantations in human beings far outweighs the supply. From the …

Peak MSC—are we there yet?

TR Olsen, KS Ng, LT Lock, T Ahsan… - Frontiers in medicine, 2018 - frontiersin.org
Human mesenchymal stem cells (hMSCs) are a critical raw material for many regenerative
medicine products, including cell-based therapies, engineered tissues, or combination …

Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo

D Nagrath, H Xu, Y Tanimura, R Zuo, F Berthiaume… - Metabolic …, 2009 - Elsevier
Fatty liver is a significant risk factor for liver transplantation, and accounts for nearly half of
the livers rejected from the donor pool. We hypothesized that metabolic preconditioning via …

Liver tissue engineering and cell sources: issues and challenges

AA Palakkan, DC Hay, AK PR, K TV… - Liver international, 2013 - Wiley Online Library
Liver diseases are of major concern as they now account for millions of deaths annually. As
a result of the increased incidence of liver disease, many patients die on the transplant …

The potential of induced pluripotent stem cell derived hepatocytes

Z Hannoun, C Steichen, N Dianat, A Weber… - Journal of …, 2016 - Elsevier
Orthotopic liver transplantation remains the only curative treatment for liver disease.
However, the number of patients who die while on the waiting list (15%) has increased in …